FDA Approves GLYBURIDE AND METFORMIN HYDROCHLORIDE — Aurobindo Pharma Limited

Aurobindo Pharma’s approval of the ANDA077870 for its generic Glyburide and Metformin Hydrochloride tablet specifically solidifies the company's position in the mature diabetes market, reinforcing its competitive pricing strategies while potentially increasing its market share against existing branded and biosimilar competition.